Pneumococcal-Vaccination for Adults starting before 60? Con

被引：0
|
作者：
Dalhoff, Klaus [1 ]
机构：
[1] Univ Klinikum Schleswig Holstein, Med Klin Pneumol 3, Kiel, Germany
来源：
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT | 2015年 / 140卷 / 23期
关键词：
DISEASE;
D O I：
10.1055/s-0041-107751
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1773 / 1774
页数：2
相关论文
共 50 条
  • [41] Risk stacking of pneumococcal vaccination indications increases mortality in unvaccinated adults with Streptococcus pneumoniae infections
    Morton, Jacob B.
    Morrill, Haley J.
    LaPlante, Kerry L.
    Caffrey, Aisling R.
    VACCINE, 2017, 35 (13) : 1692 - 1697
  • [42] Clinical practice guidelines 2019: Indian consensus-based recommendations on pneumococcal vaccination for adults
    Dhar, Raja
    Ghoshal, Aloke Gopal
    Guleria, Randeep
    Sharma, Shubham
    Kulkarni, Tarang
    Swarnakar, Rajesh
    Samaria, J. K.
    Chaudhary, Sudhir
    Gaur, S. N.
    Christopher, D. J.
    Singh, Virendra
    Abraham, Georgi
    Sarkar, Anirban
    Mukhopadhyay, Ansuman
    Panda, Jayant
    Swaminathan, Subramanian
    Nene, Amita
    Krishnan, Shyam
    Shahi, Praveen Kumar
    Sarangdhar, Nikhil
    Mishra, Narayan
    Chowdury, Susmita Roy
    Halder, Indranil
    Katiyar, S. K.
    Jain, V. K.
    Chawla, Rakesh
    Koul, Parvaiz A.
    LUNG INDIA, 2020, 37 : S19 - S29
  • [43] Influenza and pneumococcal vaccination in older adults living in nursing home: a survival analysis on the shelter study
    Poscia, Andrea
    Collamati, Agnese
    Carfi, Angelo
    Topinkova, Eva
    Richter, Tomas
    Denkinger, Michael
    Pastorino, Roberta
    Landi, Francesco
    Ricciardi, Walter
    Bernabei, Roberto
    Onder, Graziano
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2017, 27 (06) : 1016 - 1020
  • [44] Demonstration of the herd effect in adults after the implementation of pneumococcal vaccination with PCV13 in children
    Hays, C.
    Vermee, Q.
    Agathine, A.
    Dupuis, A.
    Varon, E.
    Poyart, C.
    Ploy, M. -C.
    Raymond, J.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2017, 36 (05) : 831 - 838
  • [45] Cost-effectiveness analysis of pneumococcal polysaccharide vaccination from age 60 in Sao Paulo State, Brazil
    Tonolio Neto, Joao
    Branco de Araujo, Gabriela Tannus
    Gagliardi, Anna
    Pinho, Amanda
    Durand, Laure
    Fonseca, Marcelo
    HUMAN VACCINES, 2011, 7 (10): : 1037 - 1047
  • [46] Pneumococcal vaccination coverage among adults newly diagnosed with underlying medical conditions and regional variation in the US
    Ostropolets, Anna
    Dunham, Linda Shoener
    Johnson, Kelly D.
    Liu, Junqing
    VACCINE, 2022, 40 (33) : 4856 - 4863
  • [47] Pneumococcal Vaccination in Adults Aged ≥65 Years: Cost-Effectiveness and Health Impact in US Populations
    Wateska, Angela R.
    Nowalk, Mary Patricia
    Lin, Chyongchiou J.
    Harrison, Lee H.
    Schaffner, William
    Zimmerman, Richard K.
    Smith, Kenneth J.
    AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2020, 58 (04) : 487 - 495
  • [48] The cost-effectiveness of pneumococcal vaccination in healthy adults over 50: An exploration of influential factors for Belgium
    Blommaert, Adriaan
    Bilcke, Joke
    Willem, Lander
    Verhaegen, Jan
    Goossens, Herman
    Beutels, Philippe
    VACCINE, 2016, 34 (18) : 2106 - 2112
  • [49] Pneumococcal vaccination coverage among US adults enrolled in Medicaid and newly diagnosed with underlying medical conditions
    Liu, Junqing
    Johnson, Kelly D. D.
    Dunham, Linda Shoener
    EXPERT REVIEW OF VACCINES, 2023, 22 (01) : 596 - 607
  • [50] Pneumococcal vaccination uptake and missed opportunities for vaccination among Canadian adults: A cross-sectional analysis of the Canadian Longitudinal Study on Aging (CLSA)
    Sulis, Giorgia
    Rodrigue, Valerie
    Wolfson, Christina
    McMillan, Jacqueline M.
    Kirkland, Susan A.
    Andrew, Melissa K.
    Basta, Nicole E.
    PLOS ONE, 2022, 17 (10):
12345